MANGROVE PARTNERS IM, LLC

Holdings History for ANI PHARMACEUTICALS INC - NOTE 3.000%12/0

Investment type: Debt / NOTE 3.000%12/0

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
31 Dec 2019		-2.4%	$0	0	-18,779,000	-100%		Q4 2019
30 Sep 2019	2.4%	0%	$20,140,000	18,779,000	0		107.25%	Q3 2019
30 Jun 2019	2.6%	0%	$22,147,000	18,779,000	0		117.93%	Q2 2019
31 Mar 2019	2.8%	0%	$20,614,000	18,779,000	0		109.77%	Q1 2019
31 Dec 2018	2.9%	0%	$18,849,000	18,779,000	0		100.37%	Q4 2018
30 Sep 2018	3.4%	+3.4%	$19,906,000	18,779,000	+18,760,221	+99900%	106.0%	Q3 2018
30 Jun 2018		-0%	$0	0	-18,779	-100%		Q2 2018
30 Jun 2018	0%	+0%	$21,455	18,779	+18,779	NEW	114.25%	Q2 2018
31 Mar 2018		-0%	$0	0	-18,779	-100%		Q1 2018
31 Mar 2018	0%	+0%	$20,692	18,779	+18,779	NEW	110.19%	Q1 2018
31 Dec 2017	0%	0%	$21,537	18,779	0		114.69%	Q4 2017
30 Sep 2017	0%	0%	$20,315	18,779	0		108.18%	Q3 2017
30 Jun 2017	0%	+0%	$19,817	18,779	+14,109	+302%	105.53%	Q2 2017
31 Mar 2017	0%	+0%	$4,946	4,670	+4,670	NEW	105.91%	Q1 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.